Site Search

Share

X

Search Results

Senate Votes to Remove Barriers to Precision Treatments

... Society Cancer Action Network (ACS CAN) in Indiana: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. Over the past few months, we have heard countless stories of the difficulties patients ... and the Indiana Senate for approving this legislation. We urge the House to quickly follow suit and take this significant step towards improving health outcomes and lowering health care costs." In 2024, approximately 14,280 Hoosiers will die from cancer. Improved access to biomarker testing can connect more patients to ...

Senate Committee Passes Biomarker Testing Coverage Bill

... passing the Senate Commerce and Labor Committee. SB0435 would expand coverage of biomarker testing for patients enrolled in  state employee health insurance plans and TennCare. American Cancer Society Cancer Action Network (ACS CAN) Tennessee Government Relations Director Maddie Michael attended Tuesday’s hearing to highlight the importance of this critical legislation in improving patient access to care. “Coverage for comprehensive biomarker testing will enable more patients to access the most effective treatments for their disease and can help achieve the triple aim of health care: better health outcomes, improved quality of life and reduced costs,” Michael said. Cancer patients who benefited from biomarker ...

Expand Access to Biomarker Testing in Michigan

... testing will enable more patients to access the most effective treatments for their disease and can potentially help achieve the triple aim of health care: better health outcomes, improved quality of life and reduced costs.  This legislation will ensure Iowans covered by Medicaid and state regulated ...

Expand Access to Biomarker Testing in Ohio

... and partners are working together to make sure more Ohioans can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing disparities in health outcomes by race, ethnicity, income, and geography. Insurance coverage for biomarker testing is failing to keep pace with innovations and ...

House Votes to Remove Barriers to Biomarker Testing

... Society Cancer Action Network (ACS CAN) in Ohio: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. We have heard countless stories of the difficulties patients face in attempting to ... and the Ohio House for approving this legislation. We urge the Senate to quickly follow suit and take this significant step towards improving health outcomes and lowering health care costs." In 2024, approximately 24,810 Ohioans will die from cancer. Improved access to biomarker testing can connect more patients to ...

PA House Insurance Committee Votes to Remove Barriers to Biomarker Testing

... Cancer Action Network (ACS CAN) in Pennsylvania: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past few months, we have heard countless stories of the difficulties and ... others. “We ask the House to swiftly pass House Bill 1754 so that the Senate can follow suit and take this critical step towards reducing health inequities and improving health outcomes before the end of session." For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing ...

Expand Access to Biomarker Testing in Massachusetts

... and S.809 to guarantee coverage of evidence-based biomarker testing, so that every patient has a fair shot at the most effective, personalized care. Video of jung_as_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment ...   What are H. 4339 and S. 809, and why should Massachusetts pass them? H. 4339 and S. 809 would require MassHealth and state-regulated health insurance plans to cover biomarker testing when it is supported by strong clinical evidence and guidelines. As a global leader in life sciences and cancer research, Massachusetts has an opportunity to improve patient outcomes, advance health equity, and ensure that residents of the Commonwealth have access to the most effective, personalized medical care available. This is how we ...

Legislation Introduced to Increase New Jerseyans’ Access to Biomarker Testing, the Key to Precision Medicine

... ineffective treatments and eliminate the potentially harmful, life-altering side effects of those treatments, which could also result in reduced health care costs. S3098/A4163 is a priority bill for the American Cancer Society Cancer Action Network (ACS CAN), which, last month as a part of their ... socioeconomic and geographic lines. The push to expand access to biomarker testing has drawn the support of medical professionals and public health groups representing patients across the disease spectrum; at present, over 20 organizations are working together with ACS CAN to pass ...

Access to Biomarker Testing in Tennessee

... important testing. Video of biomarker_testing_unlocking_personalized_treatments_to_improve_patient_outcomes What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ... to biomarker testing in Tennessee! Have you received biomarker testing? Share your story with us here! Resources: Fact Sheet Biomarkers and Health Equity Types of Biomarker Testing Biomarker Testing Costs and Savings Non-Oncology Biomarker Testing Patient Profiles National Coalition ...

Legislation Introduced to Increase Californians’ Access to Biomarker Testing, the Key to Precision Medicine

... — Today, State Senator Monique Limón (D-Santa Barbara) introduced legislation to ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 496 aims to enable more Californians to ... “Biomarker testing can help healthcare providers render the best treatment options for patients, which is increasingly important for cancer care and the treatment of diseases like arthritis, other immune conditions and rare diseases,” said Sen. Limón. “This bill removes barriers to ... legislation. We hope that the amended language will address Governor Newsom’s concerns and that he will take this new opportunity to reduce health disparities by bringing the promise of precision medicine to more Californians.” The percentage of clinical trials that involve biomarkers ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy